V.O. Polovynka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
V.O. Polovynka has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Vasily Beniuk
Bogomolets National Medical University, Kyiv, Ukraine
4 shared publications - I. A. Usevych
Bogomolets National Medical University, Kyiv
3 shared publications - Mykola V. Khaitovych
Bogomolets National Medical University, Kyiv, Ukraine
3 shared publications - Tetiana Kovaliuk
Bogomolets National Medical University, Kyiv
3 shared publications - Antonina Chebotarova
Bogomolets National Medical University, Kyiv, Ukraine
2 shared publications - Daria V. Turchak
Bogomolets National Medical University, Kyiv, Ukraine
2 shared publications
Latest Publications
- Open Access
- 26 February 2025
- Published by Professional Event, LLC in Reproductive health of woman
- No. 1,p. 16-21
The impact of pregnant women’s anxiety levels on the course of labor
In Ukraine, the demographic crisis exacerbates the importance of the issue of reproductive health.The objective: to study the features of uterine labor activity depending on the level of anxiety of the pregnant woman for improvement the management of pregnancy and childbirth.Materials and methods. During the preparatory stage of the study, we recorded and analyzed electromyohysterograms in 69 women in labor with its physiological course. The normal electromyography indicators with physiological contractile activity of the uterus in labor were determined. At the main stage of the study, we conducted a prospective clinical examination of 124 pregnant women who were interviewed by Spielberger State-Trait Anxiety Inventory and were subsequently divided into 3 groups depending on the level of reactive anxiety: I group – 38 women in labor with a low reactive anxiety level; II group – 35 women in labor with a moderate reactive anxiety level; III group – 51 women in labor with a high reactive anxiety level. Uterine electromyography was performed using a digital USB-oscilloscope «Hantek-6022BE». The level of anxiety in pregnant women was determined by questionnaire (Spielberger State-Trait Anxiety Inventory).Results. Normal labor activity was typical for 57.9% of pregnant women in the I group, 82.9% – in the II group and 60.8% of pregnant women in the III group (p<0.05). The frequency of weak labor activity was significantly different in pregnant women in the I and III groups – 36.8% and 23.5%, respectively, compared with the II group – 14.3% of cases (p < 0.05). Among pregnant women in the III group the hyperactive type of labor activity was detected in 9.8%, which is significantly higher than in the I and II groups (2.6% and 2.9%, respectively, p < 0.05). In pregnant women of the I and III groups the cases of discoordinated labor activity were detected, which was registered in 5.2% of pregnant women in the I group and in 5.9% in the III group, in pregnant women of the II group the discoordinated labor activity was not registered.Conclusions. The study revealed clear changes in uterine contractile activity depending on the level of reactive anxiety, in particular, the indicator of weakness of labor activity at a low reactive anxiety level was almost 2.6 times higher than the indicator in other groups, and hyperactive labor activity at a high anxiety was 3.4 times higher than the indicators of other groups.
- 26 February 2025
- Published by Professional Event, LLC in Reproductive health of woman
- No. 1,p. 16-21
Open AccessThe impact of pregnant women’s anxiety levels on the course of labor
In Ukraine, the demographic crisis exacerbates the importance of the issue of reproductive health.The objective: to study the features of uterine labor activity depending on the level of anxiety of the pregnant woman for improvement the management of pregnancy and childbirth.Materials and methods. During the preparatory stage of the study, we recorded and analyzed electromyohysterograms in 69 women in labor with its physiological course. The normal electromyography indicators with physiological contractile activity of the uterus in labor were determined. At the main stage of the study, we conducted a prospective clinical examination of 124 pregnant women who were interviewed by Spielberger State-Trait Anxiety Inventory and were subsequently divided into 3 groups depending on the level of reactive anxiety: I group – 38 women in labor with a low reactive anxiety level; II group – 35 women in labor with a moderate reactive anxiety level; III group – 51 women in labor with a high reactive anxiety level. Uterine electromyography was performed using a digital USB-oscilloscope «Hantek-6022BE». The level of anxiety in pregnant women was determined by questionnaire (Spielberger State-Trait Anxiety Inventory).Results. Normal labor activity was typical for 57.9% of pregnant women in the I group, 82.9% – in the II group and 60.8% of pregnant women in the III group (p<0.05). The frequency of weak labor activity was significantly different in pregnant women in the I and III groups – 36.8% and 23.5%, respectively, compared with the II group – 14.3% of cases (p < 0.05). Among pregnant women in the III group the hyperactive type of labor activity was detected in 9.8%, which is significantly higher than in the I and II groups (2.6% and 2.9%, respectively, p < 0.05). In pregnant women of the I and III groups the cases of discoordinated labor activity were detected, which was registered in 5.2% of pregnant women in the I group and in 5.9% in the III group, in pregnant women of the II group the discoordinated labor activity was not registered.Conclusions. The study revealed clear changes in uterine contractile activity depending on the level of reactive anxiety, in particular, the indicator of weakness of labor activity at a low reactive anxiety level was almost 2.6 times higher than the indicator in other groups, and hyperactive labor activity at a high anxiety was 3.4 times higher than the indicators of other groups.
- Open Access
- 20 November 2024
- Published by Professional Event, LLC in Reproductive health of woman
- No. 8,p. 54-60
The influence of infections and immune disorders on the development of intra-uterine pathology in women with antenatal fetal death in the anamnesis
Reproductive losses remain an urgent problem among the female population, of which antenatal fetal death (AFD) takes a leading place. The pathogenesis of this pathology is multifactorial, but at the same time, it is impossible to accurately determine the single cause of AFD.Analyzing the frequency of AFD in the world, a tendency towards repeated episodes of AFD or AFD combined with reproductive losses in early pregnancy has been established. The literature has presented data on causal relationships with existing endometrial pathology, among which the inflammatory process in the endometrium takes the leading position, and pregnancy losses with inadequate immune system response.The objective: to determine the state of the immune system, infectious profile and features of the immunohistochemical state of the endometrium in women with a history of AFD at the stage of prepregnancy preparation.Materials and methods. A clinical examination was performed on 30 patients with a history of AFD who had applied to the antenatal clinic of the municipal non-profit enterprise “Kyiv City Maternity Hospital No. 3” regarding planning their next pregnancy. A general clinical examination, a detailed analysis of the general, gynecological anamnesis, and data on the course of the previous pregnancy and childbirth were performed.All patients underwent microscopic examination of vaginal discharge stained with Gram and assessed according to the Hay–Ison criteria. The state of the endometrium was studied by microscopic examination and immunohistochemical analysis with the determination of CD-138 and CD-56. The state of the immune system was assessed by determining the activity of the cellular component (T- and B-lymphocytes) and cytokine proteins (IL-1α, IL-6, IL-8, γ-INT, TNF-α).Results. According to the somatic anamnesis, a high percentage of morbidity of the urinary system of an infectious-inflammatory nature (53.3%) and pathology of the cardiovascular system (63.3%) was determined. Among gynecological pathology inflammatory diseases of the genital tract (53.3%) and uterine leiomyoma (33.3%) predominated. In the obstetric anamnesis the spontaneous miscarriage was detected in almost every second woman (46.7%) and in every seventh woman – AFD (13.3%).During microscopic examination of vaginal discharge, the majority of women were diagnosed with stage III and IV according to the Hay–Ison criteria. During microscopic examination of the endometrium, disorders of its proliferation was detected in 2/3 of the patients, and during immunohistochemical examination – a positive reaction of CD-138 and an increased concentration of CD-56. During the study of the state of the immune system a decreased level of T-suppressors, B-lymphocytes were observed, with increased in T-killers and pro-inflammatory cytokines.Conclusions. Women with a history of antenatal fetal death have certain features of the regulatory mechanisms of the immune system both at the local and generalized levels, which prompts a detailed study and diagnosis at the pre-gravid stage when determining further reproductive plans. Research of extragenital pathology, infectious profile and the state of local immunity in the uterine cavity is especially necessary.
- 20 November 2024
- Published by Professional Event, LLC in Reproductive health of woman
- No. 8,p. 54-60
Open AccessThe influence of infections and immune disorders on the development of intra-uterine pathology in women with antenatal fetal death in the anamnesis
Reproductive losses remain an urgent problem among the female population, of which antenatal fetal death (AFD) takes a leading place. The pathogenesis of this pathology is multifactorial, but at the same time, it is impossible to accurately determine the single cause of AFD.Analyzing the frequency of AFD in the world, a tendency towards repeated episodes of AFD or AFD combined with reproductive losses in early pregnancy has been established. The literature has presented data on causal relationships with existing endometrial pathology, among which the inflammatory process in the endometrium takes the leading position, and pregnancy losses with inadequate immune system response.The objective: to determine the state of the immune system, infectious profile and features of the immunohistochemical state of the endometrium in women with a history of AFD at the stage of prepregnancy preparation.Materials and methods. A clinical examination was performed on 30 patients with a history of AFD who had applied to the antenatal clinic of the municipal non-profit enterprise “Kyiv City Maternity Hospital No. 3” regarding planning their next pregnancy. A general clinical examination, a detailed analysis of the general, gynecological anamnesis, and data on the course of the previous pregnancy and childbirth were performed.All patients underwent microscopic examination of vaginal discharge stained with Gram and assessed according to the Hay–Ison criteria. The state of the endometrium was studied by microscopic examination and immunohistochemical analysis with the determination of CD-138 and CD-56. The state of the immune system was assessed by determining the activity of the cellular component (T- and B-lymphocytes) and cytokine proteins (IL-1α, IL-6, IL-8, γ-INT, TNF-α).Results. According to the somatic anamnesis, a high percentage of morbidity of the urinary system of an infectious-inflammatory nature (53.3%) and pathology of the cardiovascular system (63.3%) was determined. Among gynecological pathology inflammatory diseases of the genital tract (53.3%) and uterine leiomyoma (33.3%) predominated. In the obstetric anamnesis the spontaneous miscarriage was detected in almost every second woman (46.7%) and in every seventh woman – AFD (13.3%).During microscopic examination of vaginal discharge, the majority of women were diagnosed with stage III and IV according to the Hay–Ison criteria. During microscopic examination of the endometrium, disorders of its proliferation was detected in 2/3 of the patients, and during immunohistochemical examination – a positive reaction of CD-138 and an increased concentration of CD-56. During the study of the state of the immune system a decreased level of T-suppressors, B-lymphocytes were observed, with increased in T-killers and pro-inflammatory cytokines.Conclusions. Women with a history of antenatal fetal death have certain features of the regulatory mechanisms of the immune system both at the local and generalized levels, which prompts a detailed study and diagnosis at the pre-gravid stage when determining further reproductive plans. Research of extragenital pathology, infectious profile and the state of local immunity in the uterine cavity is especially necessary.
- Open Access
- 31 July 2024
- Published by Professional Event, LLC in Reproductive health of woman
- No. 5,p. 66-73
Modern approach to the treatment of urinary tract infections during pregnancy
Urinary tract infections (UTIs) are an extremely common pathology among pregnant women and women in labor, the manifestation of which occurs during pregnancy. Physiological changes in a woman’s organism form an optimal background for infection or activation of the aggression of one’s own microbial environments – the microflora that colonizes the periurethral area and mostly belongs to the family of enterobacteria and staphylococci.Clinical manifestations of UTIs during pregnancy are extremely variable and do not always correspond to the usual course of the disease, which necessitates the search for modern approaches to diagnosis and treatment. Also, UTI is one of the leading factors that provoke severe pregnancy complications and can lead to adverse obstetric outcomes.The objective: to evaluate the effectiveness of the modern etiopathogenetic approach to the treatment of UTIs during pregnancy.Materials and methods. In the study, which began in 2022 and is ongoing, 1615 pregnant women at gestational ages 6-37 weeks with clinical manifestations of urinary tract infections (UTIs). This work presents the survey results of 615 pregnant women with UTIs at gestational ages from 20 to 28 weeks, both before and one month after treatment initiation. These women were monitored during their pregnancies in prenatal care clinics of municipal non-commercial enterprises across all regions of Ukraine. At the stage of prescribing treatment the examined women are divided into two groups. The main group included 374 pregnant women with established diagnoses of acute urethritis, acute cystitis, gestational pyelonephritis (GP) and asymptomatic bacteriuria (ABU), who have received antibacterial and uroseptic agents for treatment in accordance with current clinical guidelines in combination with a herbal uroantiseptic containing 120 mg of cranberry berry extract and 36 mg each of extracts of goldenseal, lovage root, rosemary, as well as auxiliary substances. The comparison group included 241 pregnant women with established diagnoses of acute urethritis, acute cystitis, GP and ABU, who were treated exclusively with antibacterial and uroseptic agents for UTIs manifestations.The effectiveness of treatment methods was evaluated on the basis of a developed questionnaire with information on the main symptoms characteristic of diseases of the urinary system, before and one month after the prescribed treatment.Results. On the background of addition to the main antibacterial and uroseptic therapy the herbal uroantiseptic, containing 120 mg of cranberry berry extract and 36 mg each of extracts of yarrow, lovage root, rosemary, as well as auxiliary substances already a month after the start of treatment, the absence of complaints was found in the majority of pregnant women in the main group, related:with frequent urination – 354 (94.6%) (comparison group – 208 (86.3%); p<0.05), the need for urgent urination – 374 (99.1%) (comparison group – 232 (96.3%); p<0.05), the feeling of incomplete emptying of the bladder – 348 (93.3%) (comparison group – 202 (83.9%); p<0.05),with pain: during urination – 369 (98.7%) (comparison group – 231 (95.9%); p<0.05), in the lower abdomen, not associated with urination – 366 (97.9%) (comparison group – 230 (95.9%); p<0.05), in the lower back – 369 (98.7%) (comparison group – 229 (95.1%); p<0.05),with discharge from the urethra not related to urination – 374 (100.0%) (comparison group – 233 (96.7%); p<0.05).Conclusions. On the background of the prescribing of a herbal uroantiseptic containing 120 mg of cranberry extract and 36 mg of extracts of yarrow, lovage root, and rosemary, as well as auxiliary substances, additionally to the main antibacterial and uroseptic therapy in pregnant women of the main group, in a significantly greater number of cases the absence of complaints, which are associated with manifestations of urinary tract infections, was determined.The use of the herbal uroantiseptic, containing 120 mg of cranberry berry extract and 36 mg of extracts of yarrow, lovage root, and rosemary, is safe and creates favorable conditions for the course of pregnancy and further childbirth due to the potentiation of the effects of antibacterial and uroseptic therapy and the effective prevention of recurrences of urinary tract infections.
- 31 July 2024
- Published by Professional Event, LLC in Reproductive health of woman
- No. 5,p. 66-73
Open AccessModern approach to the treatment of urinary tract infections during pregnancy
Urinary tract infections (UTIs) are an extremely common pathology among pregnant women and women in labor, the manifestation of which occurs during pregnancy. Physiological changes in a woman’s organism form an optimal background for infection or activation of the aggression of one’s own microbial environments – the microflora that colonizes the periurethral area and mostly belongs to the family of enterobacteria and staphylococci.Clinical manifestations of UTIs during pregnancy are extremely variable and do not always correspond to the usual course of the disease, which necessitates the search for modern approaches to diagnosis and treatment. Also, UTI is one of the leading factors that provoke severe pregnancy complications and can lead to adverse obstetric outcomes.The objective: to evaluate the effectiveness of the modern etiopathogenetic approach to the treatment of UTIs during pregnancy.Materials and methods. In the study, which began in 2022 and is ongoing, 1615 pregnant women at gestational ages 6-37 weeks with clinical manifestations of urinary tract infections (UTIs). This work presents the survey results of 615 pregnant women with UTIs at gestational ages from 20 to 28 weeks, both before and one month after treatment initiation. These women were monitored during their pregnancies in prenatal care clinics of municipal non-commercial enterprises across all regions of Ukraine. At the stage of prescribing treatment the examined women are divided into two groups. The main group included 374 pregnant women with established diagnoses of acute urethritis, acute cystitis, gestational pyelonephritis (GP) and asymptomatic bacteriuria (ABU), who have received antibacterial and uroseptic agents for treatment in accordance with current clinical guidelines in combination with a herbal uroantiseptic containing 120 mg of cranberry berry extract and 36 mg each of extracts of goldenseal, lovage root, rosemary, as well as auxiliary substances. The comparison group included 241 pregnant women with established diagnoses of acute urethritis, acute cystitis, GP and ABU, who were treated exclusively with antibacterial and uroseptic agents for UTIs manifestations.The effectiveness of treatment methods was evaluated on the basis of a developed questionnaire with information on the main symptoms characteristic of diseases of the urinary system, before and one month after the prescribed treatment.Results. On the background of addition to the main antibacterial and uroseptic therapy the herbal uroantiseptic, containing 120 mg of cranberry berry extract and 36 mg each of extracts of yarrow, lovage root, rosemary, as well as auxiliary substances already a month after the start of treatment, the absence of complaints was found in the majority of pregnant women in the main group, related:with frequent urination – 354 (94.6%) (comparison group – 208 (86.3%); p<0.05), the need for urgent urination – 374 (99.1%) (comparison group – 232 (96.3%); p<0.05), the feeling of incomplete emptying of the bladder – 348 (93.3%) (comparison group – 202 (83.9%); p<0.05),with pain: during urination – 369 (98.7%) (comparison group – 231 (95.9%); p<0.05), in the lower abdomen, not associated with urination – 366 (97.9%) (comparison group – 230 (95.9%); p<0.05), in the lower back – 369 (98.7%) (comparison group – 229 (95.1%); p<0.05),with discharge from the urethra not related to urination – 374 (100.0%) (comparison group – 233 (96.7%); p<0.05).Conclusions. On the background of the prescribing of a herbal uroantiseptic containing 120 mg of cranberry extract and 36 mg of extracts of yarrow, lovage root, and rosemary, as well as auxiliary substances, additionally to the main antibacterial and uroseptic therapy in pregnant women of the main group, in a significantly greater number of cases the absence of complaints, which are associated with manifestations of urinary tract infections, was determined.The use of the herbal uroantiseptic, containing 120 mg of cranberry berry extract and 36 mg of extracts of yarrow, lovage root, and rosemary, is safe and creates favorable conditions for the course of pregnancy and further childbirth due to the potentiation of the effects of antibacterial and uroseptic therapy and the effective prevention of recurrences of urinary tract infections.
- Open Access
- 30 June 2023
- Published by Professional Event, LLC in Reproductive health of woman
- No. 4,p. 50-58
Features of disorders and methods of correction of the hemostasis system in women with antenatal fetal death
The improvement of the providing medical services quality to pregnant women remains an urgent issue in modern obstetrics. Women with perinatal losses deserve special attention, especially in the second half of pregnancy. Changes in the hemostasis system are an integral part of the development of pregnancy. The tendency to hypercoagulation has significant pathogenetic significance and can be the cause of a number of complications – miscarriage in the I trimester of pregnancy and preeclampsia, premature birth, antenatal fetal death (AFD) – in the II and III trimesters of pregnancy. Also, pregnancy is a background process for the activation of a number of diseases, in particular hereditary thrombophilia.The objective: to evaluate the changes in the hemostasis system in women with antenatal fetal death and the effectiveness of the use of low molecular weight heparins for the correction of disorders in the hemostasis system in this category of patients during childbirth and in the postpartum period.Materials and methods. 72 women were examined, including 42 pregnant women with AFD (main group) and 30 pregnant women with a physiological course of pregnancy, childbirth and the postpartum period (control group). The state of the hemostasis system was studied using a standard coagulogram. D-dimer was determined by immunoturbometric analysis.To assess the state of the hemostasis system, the following biochemical tests were used: procoagulant link – fibrinogen content and indicators: prothrombin index, activated partial thrombin time (APTT), thrombin time (TP), ancistrone time (AT), soluble fibrinogen-monomer complex (SFMC), factor X (FX); to evaluate the antithrombin system, the content of antithrombin-III (AT-III), protein C were determined; to characterize the state of the fibrinolytic system – the amount of plasminogen, α2-antiplasmin, fibrinogen degradation products (FDC).Thrombophilia markers and antiphospholipid antibodies were also determined. The preference was given to vaginal childbirth. During childbirth, mechanical compression of the lower limbs was applied using special compression stockings (compression level 2). In 12 hours after delivery thromboprophylaxis with low molecular weight heparins was started, the drug of choice being enoxaparin sodium. After 48 hours of the postpartum period, a comparative analysis of coagulogram indicators was performed to further determine the timing of thromboprophylaxis.Results. Analysis of family thrombotic anamnesis revealed risk factors in 12 (28.6%) patients of the main group. In close relatives of the first line, the presence of peripheral vein thrombosis was found – 5 (41.7%) cases, myocardial infarction under the age of 45 – 3 (25.0%) cases, pulmonary embolism – 1 (8.3%) case, transient ischemic attack of the brain – 3 (25.0%).In the control group only 2 (6.6%) patients had a family history of venous thromboembolism in first-line relatives. The analysis of the coagulation system shows significantly higher fibrinogen values (the main group – 5.3±0.2 g/l, the control group – 4.3±0.1 g/l; p<0.05), functional FX activity (the main group – 149.3±3.1%, control group – 107.3±2.7%; p<0.05), SFMC (main group – 15.9±1.2 μg/ml, control group – 7.8±0.9 μg/ml; p<0.05) and D-dimer (main group – 4.4±0.25 μg/ml, control group – 0.7±0.2 μg/ml; p< 0.05) in pregnant women of the main group. An increase in these indicators is a predictor of thrombus formation, activation of blood coagulation by the internal pathway with a decrease in the antithrombin reserve due to FX.During the correlation analysis, a strong direct relationship (r=0.8633) was established between the indicators of SFMC and FX in the blood serum of pregnant women of the main group, the combination of which determines the tendency to clot formation. Determination of markers for the most common types of thrombophilia shows the dominance of hereditary forms (prothrombin, Leiden mutation, MTHFR) in 43% of pregnant women of the main group.The implementation of the proposed treatment approach contributed to a significant decrease in the average concentration of fibrinogen 48 hours after delivery in postpartum women of the main group (main group: before delivery – 5.3±0.2 g/l, after 48 hours after delivery – 3.9±0.3 g/l; control group: 48 hours after delivery – 3.2±0.2 g/l; p<0.05) in combination with a synergistic decrease in the average indicators of SFMC (main group: before delivery – 15.9±1.2 μg/ml, 48 hours after delivery – 6.2±0.2 μg/ml; control group: 48 hours after delivery – 5.4±0.3 μg/ml; p<0.05) and FX (main group: before delivery – 149.3±3.1%, after 48 hours after delivery – 103.1±3.6%; control group: after 48 hours after delivery – 117.1±4.1%; p<0.05).Conclusions. Increased coagulation function was confirmed in pregnant women with antenatal fetal death (AFD). Thanks to the proposed method of correcting disorders in the hemostasis system, a decrease in the frequency of postpartum thromboembolism in women with AFD is achieved, as well as an improvement in the main indicators of the hemostasis system. This prevents the emergence of a chronic form of the syndrome of disseminated intravascular blood coagulation which is developed in the cases of AFD.
- 30 June 2023
- Published by Professional Event, LLC in Reproductive health of woman
- No. 4,p. 50-58
Open AccessFeatures of disorders and methods of correction of the hemostasis system in women with antenatal fetal death
The improvement of the providing medical services quality to pregnant women remains an urgent issue in modern obstetrics. Women with perinatal losses deserve special attention, especially in the second half of pregnancy. Changes in the hemostasis system are an integral part of the development of pregnancy. The tendency to hypercoagulation has significant pathogenetic significance and can be the cause of a number of complications – miscarriage in the I trimester of pregnancy and preeclampsia, premature birth, antenatal fetal death (AFD) – in the II and III trimesters of pregnancy. Also, pregnancy is a background process for the activation of a number of diseases, in particular hereditary thrombophilia.The objective: to evaluate the changes in the hemostasis system in women with antenatal fetal death and the effectiveness of the use of low molecular weight heparins for the correction of disorders in the hemostasis system in this category of patients during childbirth and in the postpartum period.Materials and methods. 72 women were examined, including 42 pregnant women with AFD (main group) and 30 pregnant women with a physiological course of pregnancy, childbirth and the postpartum period (control group). The state of the hemostasis system was studied using a standard coagulogram. D-dimer was determined by immunoturbometric analysis.To assess the state of the hemostasis system, the following biochemical tests were used: procoagulant link – fibrinogen content and indicators: prothrombin index, activated partial thrombin time (APTT), thrombin time (TP), ancistrone time (AT), soluble fibrinogen-monomer complex (SFMC), factor X (FX); to evaluate the antithrombin system, the content of antithrombin-III (AT-III), protein C were determined; to characterize the state of the fibrinolytic system – the amount of plasminogen, α2-antiplasmin, fibrinogen degradation products (FDC).Thrombophilia markers and antiphospholipid antibodies were also determined. The preference was given to vaginal childbirth. During childbirth, mechanical compression of the lower limbs was applied using special compression stockings (compression level 2). In 12 hours after delivery thromboprophylaxis with low molecular weight heparins was started, the drug of choice being enoxaparin sodium. After 48 hours of the postpartum period, a comparative analysis of coagulogram indicators was performed to further determine the timing of thromboprophylaxis.Results. Analysis of family thrombotic anamnesis revealed risk factors in 12 (28.6%) patients of the main group. In close relatives of the first line, the presence of peripheral vein thrombosis was found – 5 (41.7%) cases, myocardial infarction under the age of 45 – 3 (25.0%) cases, pulmonary embolism – 1 (8.3%) case, transient ischemic attack of the brain – 3 (25.0%).In the control group only 2 (6.6%) patients had a family history of venous thromboembolism in first-line relatives. The analysis of the coagulation system shows significantly higher fibrinogen values (the main group – 5.3±0.2 g/l, the control group – 4.3±0.1 g/l; p<0.05), functional FX activity (the main group – 149.3±3.1%, control group – 107.3±2.7%; p<0.05), SFMC (main group – 15.9±1.2 μg/ml, control group – 7.8±0.9 μg/ml; p<0.05) and D-dimer (main group – 4.4±0.25 μg/ml, control group – 0.7±0.2 μg/ml; p< 0.05) in pregnant women of the main group. An increase in these indicators is a predictor of thrombus formation, activation of blood coagulation by the internal pathway with a decrease in the antithrombin reserve due to FX.During the correlation analysis, a strong direct relationship (r=0.8633) was established between the indicators of SFMC and FX in the blood serum of pregnant women of the main group, the combination of which determines the tendency to clot formation. Determination of markers for the most common types of thrombophilia shows the dominance of hereditary forms (prothrombin, Leiden mutation, MTHFR) in 43% of pregnant women of the main group.The implementation of the proposed treatment approach contributed to a significant decrease in the average concentration of fibrinogen 48 hours after delivery in postpartum women of the main group (main group: before delivery – 5.3±0.2 g/l, after 48 hours after delivery – 3.9±0.3 g/l; control group: 48 hours after delivery – 3.2±0.2 g/l; p<0.05) in combination with a synergistic decrease in the average indicators of SFMC (main group: before delivery – 15.9±1.2 μg/ml, 48 hours after delivery – 6.2±0.2 μg/ml; control group: 48 hours after delivery – 5.4±0.3 μg/ml; p<0.05) and FX (main group: before delivery – 149.3±3.1%, after 48 hours after delivery – 103.1±3.6%; control group: after 48 hours after delivery – 117.1±4.1%; p<0.05).Conclusions. Increased coagulation function was confirmed in pregnant women with antenatal fetal death (AFD). Thanks to the proposed method of correcting disorders in the hemostasis system, a decrease in the frequency of postpartum thromboembolism in women with AFD is achieved, as well as an improvement in the main indicators of the hemostasis system. This prevents the emergence of a chronic form of the syndrome of disseminated intravascular blood coagulation which is developed in the cases of AFD.
- Open Access
- 30 September 2022
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 18 (3) , 103-111
TEACHING CLINICAL PHARMACOLOGY OF UNDERGRADUATE MEDICAL STUDENTS IN EUROPE: CURRENT TRENDS AND PROSPECTS. Review
Relevance. Among the professional competencies, a graduate of a medical faculty should not only determine drugs for the treatment of typical diseases, but also be able to correct errors in prescribing; warn, identify and report adverse drug reactions; advise patients on the correct intake of drug, etc., providing effective, safe and economically justified pharmacotherapy. These professional competencies are acquired when studying the discipline "Clinical pharmacology”. Objective – to consider the current data on teaching of the discipline "Clinical pharmacology" to students of medical faculties in European institutions of higher education. Methods. Analysis of data presented in PubMed using the keywords "clinical pharmacology", "undergraduate education", "medical". Results. Clinical pharmacology, as an educational discipline, is based on the data of evidence-based medicine and modern treatment standards, but at the same time teaches the personalized use of drugs (based on deep knowledge of pharmacokinetics and pharmacogenetics), while the patient receives the "right" drug, in the "right" dose, which allows you to minimize the risk of side effects and reduce adherence to therapy. Every £1 invested in clinical pharmacology saves £6 by reducing prescribing errors and adverse drug reactions, tackling polypharmacy and more. In 2018, European experts in clinical pharmacology and therapeutics reached a consensus on the key learning outcomes of students of medical faculties, - 34 competencies were developed (knowledge with 20 subcategories, skills with 11 subcategories, attitudes – with 3 subcategories), a plan for an integrated context-oriented European educational program in clinical pharmacology and therapy. Conclusions. The developed system of problem-oriented, integrated into the educational program of medicine, study of “Clinical pharmacology and therapy" in European institutions of higher education allows to ensure a uniform standard of prescription of drugs by graduates of medical faculties. Актуальність. Випускник медичного факультету серед професійних компетенцій має не лише визначати лікарські засоби для лікування типових захворювань, але і вміти корегувати помилки у призначенні лікарських засобів; попереджувати, виявляти та повідомляти про побічні реакції на лікарські засоби; консультувати пацієнтів щодо правильного прийому лікарських засобів тощо, забезпечуючи ефективну, безпечну та економічно обґрунтовану фармакотерапію. Вказані професійні компетенції набуваються при вивченні дисципліни «клінічна фармакологія» Ціль: розглянути сучасні дані щодо викладання дисципліни «клінічна фармакологія» студентам медичних факультетів у європейських закладах вищої освіти. Методи. Аналіз даних, представлених в PubMed за ключовими словами «клінічна фармакологія», «додипломна освіта», «медичний». Результати. Клінічна фармакологія, як навчальна дисципліна, базується на даних доказової медицини та сучасних стандартів лікування, але при цьому вчить персоналізованому застосуванню лікарських засобів (на основі глибоких знань фармакокінетики та фармакогенетики), при цьому пацієнт отримує «правильний» препарат, у «правильній» дозі, що дозволяє мінімізувати ризик виникнення побічних реакцій та зниження прихильності до терапії. Кожен 1 фунт стерлінгів, інвестований у клінічну фармакологію, заощаджує 6 фунтів стерлінгів за рахунок зменшення кількості помилок при призначенні та побічних ефектів від лікарських засобів, протидії поліфармації тощо. Європейські експерти з клінічної фармакології та терапії у 2018 році досягли консенсусу щодо ключових результатів навчання студентів медичних факультетів, розроблено 34 компетенції (знання за 20 субкатегоріями, навички за 11 субкатегоріями, ставлення – за 3 субкатегоріями), план інтегрованої контекстно-орієнтованої європейської освітньої програми з клінічної фармакології та терапії. Висновки. Розроблена система проблемно-орієнтованого інтегрованого в освітню програму з медицини вивчення дисципліни «Клінічна фармакологія та терапія» в європейських закладах вищої освіти дозволяє забезпечити єдиний стандарт призначення лікарських засобів випускниками медичних...
- 30 September 2022
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 18 (3) , 103-111
Open AccessTEACHING CLINICAL PHARMACOLOGY OF UNDERGRADUATE MEDICAL STUDENTS IN EUROPE: CURRENT TRENDS AND PROSPECTS. Review
Relevance. Among the professional competencies, a graduate of a medical faculty should not only determine drugs for the treatment of typical diseases, but also be able to correct errors in prescribing; warn, identify and report adverse drug reactions; advise patients on the correct intake of drug, etc., providing effective, safe and economically justified pharmacotherapy. These professional competencies are acquired when studying the discipline "Clinical pharmacology”. Objective – to consider the current data on teaching of the discipline "Clinical pharmacology" to students of medical faculties in European institutions of higher education. Methods. Analysis of data presented in PubMed using the keywords "clinical pharmacology", "undergraduate education", "medical". Results. Clinical pharmacology, as an educational discipline, is based on the data of evidence-based medicine and modern treatment standards, but at the same time teaches the personalized use of drugs (based on deep knowledge of pharmacokinetics and pharmacogenetics), while the patient receives the "right" drug, in the "right" dose, which allows you to minimize the risk of side effects and reduce adherence to therapy. Every £1 invested in clinical pharmacology saves £6 by reducing prescribing errors and adverse drug reactions, tackling polypharmacy and more. In 2018, European experts in clinical pharmacology and therapeutics reached a consensus on the key learning outcomes of students of medical faculties, - 34 competencies were developed (knowledge with 20 subcategories, skills with 11 subcategories, attitudes – with 3 subcategories), a plan for an integrated context-oriented European educational program in clinical pharmacology and therapy. Conclusions. The developed system of problem-oriented, integrated into the educational program of medicine, study of “Clinical pharmacology and therapy" in European institutions of higher education allows to ensure a uniform standard of prescription of drugs by graduates of medical faculties. Актуальність. Випускник медичного факультету серед професійних компетенцій має не лише визначати лікарські засоби для лікування типових захворювань, але і вміти корегувати помилки у призначенні лікарських засобів; попереджувати, виявляти та повідомляти про побічні реакції на лікарські засоби; консультувати пацієнтів щодо правильного прийому лікарських засобів тощо, забезпечуючи ефективну, безпечну та економічно обґрунтовану фармакотерапію. Вказані професійні компетенції набуваються при вивченні дисципліни «клінічна фармакологія» Ціль: розглянути сучасні дані щодо викладання дисципліни «клінічна фармакологія» студентам медичних факультетів у європейських закладах вищої освіти. Методи. Аналіз даних, представлених в PubMed за ключовими словами «клінічна фармакологія», «додипломна освіта», «медичний». Результати. Клінічна фармакологія, як навчальна дисципліна, базується на даних доказової медицини та сучасних стандартів лікування, але при цьому вчить персоналізованому застосуванню лікарських засобів (на основі глибоких знань фармакокінетики та фармакогенетики), при цьому пацієнт отримує «правильний» препарат, у «правильній» дозі, що дозволяє мінімізувати ризик виникнення побічних реакцій та зниження прихильності до терапії. Кожен 1 фунт стерлінгів, інвестований у клінічну фармакологію, заощаджує 6 фунтів стерлінгів за рахунок зменшення кількості помилок при призначенні та побічних ефектів від лікарських засобів, протидії поліфармації тощо. Європейські експерти з клінічної фармакології та терапії у 2018 році досягли консенсусу щодо ключових результатів навчання студентів медичних факультетів, розроблено 34 компетенції (знання за 20 субкатегоріями, навички за 11 субкатегоріями, ставлення – за 3 субкатегоріями), план інтегрованої контекстно-орієнтованої європейської освітньої програми з клінічної фармакології та терапії. Висновки. Розроблена система проблемно-орієнтованого інтегрованого в освітню програму з медицини вивчення дисципліни «Клінічна фармакологія та терапія» в європейських закладах вищої освіти дозволяє забезпечити єдиний стандарт призначення лікарських засобів випускниками медичних...
- Open Access
- 30 June 2022
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 18 (2) , 22-28
PRE-AUTHORIZATION OF ANTIBACTERIAL DRUGS IN THE TREATMENT OF CHILDREN WITH ACUTE PERIANAL ABSCESS
Relevance. Acute perianal abscess mainly occurs in boys in the first year of life, but can occur in girls and in older age, often progressing to anal fistula. After surgery and drainage, it is advisable to administer antibiotics because antibiotic therapy reduces the risk of fistula. Objective is to evaluate the possibility of using antibacterial drugs, mainly Access and Watch groups with a narrow spectrum of action, in the treatment of children with perianal abscess. Materials and methods. A retrospective analysis of the results of treatment of 26 boys and 4 girls aged 3 months to 17 years. The study of biological material was performed by the culture method. Species identification of microorganisms was performed on automatic microbiological analyzers Vitek2Compact (bioMerieux) and VitekMS (bioMerieux). All children underwent surgical removal of the crypt and drainage of the abscess. Antibacterial therapy was prescribed for a period of 3 to 12 days, depending on the course of the disease and the results of microbiological monitoring. Results. A total of 48 prescriptions of antibacterial agents were made, of which 33 (68.7%) were antibacterial agents from the Access group. 16 children were treated only with Access group antibacterial drugs. Of these, 14 children, mostly in the first year of life, received only narrow-spectrum antibacterial agents (amikacin in monotherapy or in combination with metronidazole, clindamycin). In the scheme of treatment of children 14 children, mostly older people included a drug from the group of cephalosporins of the third generation. Half of these patients also received amikacin and 3 received metronidazole. Conclusions. Children with acute perianal abscess in the first year of life should be treated as mono- or combination therapy with narrow-spectrum drugs from the Access group, while older children - with the inclusion of a combination of antimicrobial drugs broad-spectrum drugs Watch group.
- 30 June 2022
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 18 (2) , 22-28
Open AccessPRE-AUTHORIZATION OF ANTIBACTERIAL DRUGS IN THE TREATMENT OF CHILDREN WITH ACUTE PERIANAL ABSCESS
Relevance. Acute perianal abscess mainly occurs in boys in the first year of life, but can occur in girls and in older age, often progressing to anal fistula. After surgery and drainage, it is advisable to administer antibiotics because antibiotic therapy reduces the risk of fistula. Objective is to evaluate the possibility of using antibacterial drugs, mainly Access and Watch groups with a narrow spectrum of action, in the treatment of children with perianal abscess. Materials and methods. A retrospective analysis of the results of treatment of 26 boys and 4 girls aged 3 months to 17 years. The study of biological material was performed by the culture method. Species identification of microorganisms was performed on automatic microbiological analyzers Vitek2Compact (bioMerieux) and VitekMS (bioMerieux). All children underwent surgical removal of the crypt and drainage of the abscess. Antibacterial therapy was prescribed for a period of 3 to 12 days, depending on the course of the disease and the results of microbiological monitoring. Results. A total of 48 prescriptions of antibacterial agents were made, of which 33 (68.7%) were antibacterial agents from the Access group. 16 children were treated only with Access group antibacterial drugs. Of these, 14 children, mostly in the first year of life, received only narrow-spectrum antibacterial agents (amikacin in monotherapy or in combination with metronidazole, clindamycin). In the scheme of treatment of children 14 children, mostly older people included a drug from the group of cephalosporins of the third generation. Half of these patients also received amikacin and 3 received metronidazole. Conclusions. Children with acute perianal abscess in the first year of life should be treated as mono- or combination therapy with narrow-spectrum drugs from the Access group, while older children - with the inclusion of a combination of antimicrobial drugs broad-spectrum drugs Watch group.
- Open Access
- 30 March 2022
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 18 (1) , 35-39
PROBLEMATIC POLYPHARMACY IN OUTPATIENT THERAPY OF CHILDREN: POTENTIAL RISKS OF DRUG INTERACTIONS
Relevance. The development of medical and pharmaceutical technologies has allowed ensuring the quality of life of children even with severe chronic diseases, but often the treatment of such children is associated with polypharmacy. Objective is to assess the risks of drug interactions in children with polypharmacy. Materials and methods. The course of pharmacotherapy of 54 children with atopic diseases, diseases of the gastrointestinal tract, parasitic infestation, inflammatory diseases of the genital organs, etc. aged from birth to 17 years, who received simultaneously from 5 to 11 drugs (average 6.4 ± 1.5 drugs) Results. Problematic polypharmacy was founded in 31 children (75.0% of schoolchildren and 38.5% of preschool children) with polypharmacy. Among them, 22 patients (71.0%) had pharmacokinetic risks, and 17 children (54.8%) had pharmacodynamic interactions. Among the causes of pharmacokinetic interaction – the use of inhibitors (omeprazole, etc.) and inducers (phenobarbital, St. John's wort, etc.) metabolism, pharmacodynamic interaction – the simultaneous use of several glucocorticoids, drugs with similar organ toxicity, and more. Conclusions. Outpatient use of 5 or more drugs is combined in more than half of children at risk of their interaction, development of side effects or reduced effectiveness of treatment.
- 30 March 2022
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 18 (1) , 35-39
Open AccessPROBLEMATIC POLYPHARMACY IN OUTPATIENT THERAPY OF CHILDREN: POTENTIAL RISKS OF DRUG INTERACTIONS
Relevance. The development of medical and pharmaceutical technologies has allowed ensuring the quality of life of children even with severe chronic diseases, but often the treatment of such children is associated with polypharmacy. Objective is to assess the risks of drug interactions in children with polypharmacy. Materials and methods. The course of pharmacotherapy of 54 children with atopic diseases, diseases of the gastrointestinal tract, parasitic infestation, inflammatory diseases of the genital organs, etc. aged from birth to 17 years, who received simultaneously from 5 to 11 drugs (average 6.4 ± 1.5 drugs) Results. Problematic polypharmacy was founded in 31 children (75.0% of schoolchildren and 38.5% of preschool children) with polypharmacy. Among them, 22 patients (71.0%) had pharmacokinetic risks, and 17 children (54.8%) had pharmacodynamic interactions. Among the causes of pharmacokinetic interaction – the use of inhibitors (omeprazole, etc.) and inducers (phenobarbital, St. John's wort, etc.) metabolism, pharmacodynamic interaction – the simultaneous use of several glucocorticoids, drugs with similar organ toxicity, and more. Conclusions. Outpatient use of 5 or more drugs is combined in more than half of children at risk of their interaction, development of side effects or reduced effectiveness of treatment.
- Open Access
- 31 May 2021
- Published by Professional Event, LLC in Reproductive health of woman
- Vol. 4 (4) , 58-62
Correction of urodynamic disorders in women with genitourinary syndrome using a fractional CO2-laser
Стаття присвячена корекції уродинамічних порушень у жінок з генітоуринарним синдромом шляхом застосування фракційного СО2-лазера. Сьогодні розвиток генітоуринарного синдрому є актуальною проблемою серед жінок різного віку. Генітоуринарні розлади – це комплекс симптомів, пов’язаних з розвитком атрофічних і дистрофічних процесів в естрогенозалежних тканинах (піхва, сечівник, сечовий міхур, нижня третина сечоводів, зв’язки і м’язи тазового дна). Мета дослідження: визначення та патогенетичне обґрунтування ефективності використання СО2-лазера у лікуванні уродинамічних порушень у пацієнток у пременопаузальний період з генітоуринарним синдромом. Матеріали та методи. Обстежено 130 пацієнток з симптомами генітоуринарного синдрому. Залежно від призначеної терапії їх розподілено на дві групи. До основної групи увійшли 56 жінок, яким запропоновано терапію із застосуванням СО2-лазера. До групи порівняння включено 74 жінки, яким призначали терапію з місцевим застосуванням естріолу. З метою оцінювання ефективності лікування та функціонального стану нижніх сечовидільних шляхів проводили комплексне уродинамічне дослідження до лікування та після нього. Результати. Середній вік пацієнток обстежених груп становив 47,2±2,5 року. Після проведеного лікування за даними уродинамічного дослідження в основній групі відзначено збільшення максимального внутрішньоуретрального тиску – з 16,8±17,9 до 26,7±21,2 мм вод.ст. (рЗаключення. Результати дослідження свідчать, що метод лазерної фракційної абляції вагінального епітелію та вульви MonaLisaTouch є високоефективним порівняно з місцевою гормональною терапією і може бути рекомендований як монотерапія урогінекологічних розладів та дисфункції тазового дна.
- 31 May 2021
- Published by Professional Event, LLC in Reproductive health of woman
- Vol. 4 (4) , 58-62
Open AccessCorrection of urodynamic disorders in women with genitourinary syndrome using a fractional CO2-laser
Стаття присвячена корекції уродинамічних порушень у жінок з генітоуринарним синдромом шляхом застосування фракційного СО2-лазера. Сьогодні розвиток генітоуринарного синдрому є актуальною проблемою серед жінок різного віку. Генітоуринарні розлади – це комплекс симптомів, пов’язаних з розвитком атрофічних і дистрофічних процесів в естрогенозалежних тканинах (піхва, сечівник, сечовий міхур, нижня третина сечоводів, зв’язки і м’язи тазового дна). Мета дослідження: визначення та патогенетичне обґрунтування ефективності використання СО2-лазера у лікуванні уродинамічних порушень у пацієнток у пременопаузальний період з генітоуринарним синдромом. Матеріали та методи. Обстежено 130 пацієнток з симптомами генітоуринарного синдрому. Залежно від призначеної терапії їх розподілено на дві групи. До основної групи увійшли 56 жінок, яким запропоновано терапію із застосуванням СО2-лазера. До групи порівняння включено 74 жінки, яким призначали терапію з місцевим застосуванням естріолу. З метою оцінювання ефективності лікування та функціонального стану нижніх сечовидільних шляхів проводили комплексне уродинамічне дослідження до лікування та після нього. Результати. Середній вік пацієнток обстежених груп становив 47,2±2,5 року. Після проведеного лікування за даними уродинамічного дослідження в основній групі відзначено збільшення максимального внутрішньоуретрального тиску – з 16,8±17,9 до 26,7±21,2 мм вод.ст. (рЗаключення. Результати дослідження свідчать, що метод лазерної фракційної абляції вагінального епітелію та вульви MonaLisaTouch є високоефективним порівняно з місцевою гормональною терапією і може бути рекомендований як монотерапія урогінекологічних розладів та дисфункції тазового дна.
- Open Access
- 28 February 2020
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 16 (1) , 17-21
RISK FACTORS OF PRE-CANCER CERVICAL DISEASES IN WOMEN OF REPRODUCTIVE AGE
Relevance. Today, the nature of the impact of the inflammatory process caused by Trichomonas infection on the persistence of HPV and immune response, as a consequence of the progression of intraepithelial lesions of the cervix, is not fully understood. Objectives: based on a retrospective clinical and statistical analysis to determine the risk factors for cervical dysplasia in women of reproductive age. Materials and methods. A clinical and statistical analysis for 392 medical records of patients of reproductive age with verified HPV and Trichomonas Vaginalis, who received pathogenetic therapy at the clinical bases of the Bogomolets National Medical University Obstetrics and Gynecology № 3 Department and LLC "Clinic Profimed" for 2015-2019. As a result of a retrospective study of patients systematized by age, complaints, the presence of genital and extragenital pathology, reproductive history and the state of reproductive function, social status. Results. According to the analysis of anamnesis indicators, the main risk factors for precancerous cervical conditions were: early onset of sexual life, menstrual disorders (29.1%), high incidence of childhood infectious diseases (63.5%), somatic pathology (71.2 %), irregular use of barrier contraception (19.9%), genital diseased caused by sexually transmitted infections (STD), including HPV and Trichomonas Vaginalis, frequent abortions (41.6%) and childbirth with cervical trauma, low level of medical and sexual cultures and smoking (65.3%). The systemic negative impact of numerous risk factors on the body contributed to cervical intraepithelial neoplasia (CIN) development in women of reproductive age. Conclusion. The retrospective study proves the need for stratification of patients with for CIN risk, requires management of cervical pathology in women with HPV and detected Trichomonas Vaginalis, which will increase the effectiveness of diagnosis, treatment and recurrence prevention.
- 28 February 2020
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 16 (1) , 17-21
Open AccessRISK FACTORS OF PRE-CANCER CERVICAL DISEASES IN WOMEN OF REPRODUCTIVE AGE
Relevance. Today, the nature of the impact of the inflammatory process caused by Trichomonas infection on the persistence of HPV and immune response, as a consequence of the progression of intraepithelial lesions of the cervix, is not fully understood. Objectives: based on a retrospective clinical and statistical analysis to determine the risk factors for cervical dysplasia in women of reproductive age. Materials and methods. A clinical and statistical analysis for 392 medical records of patients of reproductive age with verified HPV and Trichomonas Vaginalis, who received pathogenetic therapy at the clinical bases of the Bogomolets National Medical University Obstetrics and Gynecology № 3 Department and LLC "Clinic Profimed" for 2015-2019. As a result of a retrospective study of patients systematized by age, complaints, the presence of genital and extragenital pathology, reproductive history and the state of reproductive function, social status. Results. According to the analysis of anamnesis indicators, the main risk factors for precancerous cervical conditions were: early onset of sexual life, menstrual disorders (29.1%), high incidence of childhood infectious diseases (63.5%), somatic pathology (71.2 %), irregular use of barrier contraception (19.9%), genital diseased caused by sexually transmitted infections (STD), including HPV and Trichomonas Vaginalis, frequent abortions (41.6%) and childbirth with cervical trauma, low level of medical and sexual cultures and smoking (65.3%). The systemic negative impact of numerous risk factors on the body contributed to cervical intraepithelial neoplasia (CIN) development in women of reproductive age. Conclusion. The retrospective study proves the need for stratification of patients with for CIN risk, requires management of cervical pathology in women with HPV and detected Trichomonas Vaginalis, which will increase the effectiveness of diagnosis, treatment and recurrence prevention.